Alicia Pan is a student from the city of Vienna, Virginia, and has garnered national recognition for her scientific research and academic achievements. Through her research at the National Institutes of Health on the motor protein kinesin, she and her team mate discovered the next anticancer drug target: an extended form of kinesin with a new extensible motif it uses as a leg to walk on the microtubule with. Using this discovery, they disproved a popular and widely-accepted kinesin walking mechanism theory and proposed their own walking mechanism with none of the difficulties of the current models. She and her team mate were awarded the Siemens National Regional Finalist title in 2017 for their revolutionary work, with their project being one of 30 selected nationally from a pool of over 2,000 applicants. At her school, she is the President and Founder of the Girls Who Code program, working with her school to provide all students with an accessible coding curriculum. As the Chairman of Community Service Projects for the Future Business Leaders of America (FBLA), she has been recognized as a state and regional FBLA champion. Alicia has placed first in the Virginia state Business Law competitions and first in the Regional Business Law competitions.